menu
menu

RSV Vaccine Trial

Description

RSV (Respiratory Syncytial Virus) is a virus that commonly causes respiratory infections, such as bronchiolitis and pneumonia, particularly in young children and older adults.

Over 177,000 adults over the age of 65 are hospitalized with severe RSV infection in the U.S. each year. See if you qualify to help trial  a new RSV vaccine.

 

Qualification:

  • Be 80 years of age or older
  • Be generally healthy with few or no major health concerns
  • Not have had prior allergic reactions to vaccines
  • Additional criteria may apply

 

Benefits:

  • Receive an pre-approved vaccine at no additional cost
  • Receive compensation up to $1,970
  • Receive access to doctors and health care professionals at no additional cost

 

Overview
Sponsor: Moderna Inc.
Location: Seattle, WA
Type: Clinical